Latest From Scrip Team
Pipeline Watch: Eight Approvals And 15 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Sypre Therapeutics, Evelo Biosciences, Amylyx Pharmaceuticals And More
Recent executive moves in the industry include changes at the top at Spyre Therapeutics, Neopharmed Gentili and CytoDyn.
Pipeline Watch: 12 Approvals And Nine Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip Awards Lifetime Achievement Winner Jeremy Levin Urges Pharma To Put Humanity First
In accepting Scrip’s Lifetime Achievement Award, Ovid Therapeutics’ CEO called on pharma to show responsible leadership and live up to its potential to do good for society.
Executives On The Move: New CEOs at Novavax, Homology Medicines, Race Oncology And More
Recent moves in the industry include internal rejigs at Homology Medicines, Virpax Pharmaceuticals, CytoDyn and Applied Therapeutics, plus new board members at Neuroscientific Biopharmaceuticals.
Pipeline Watch: AHA And AASLD Meetings Dominate
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.